Evaluation of a Behavioral Program for Migraineurs in the Emergency Department.

NCT02643719 NA WITHDRAWN

Randomized pilot feasibility study evaluating the impact of introducing behavioral treatment for migraine in the Emergency Department (ED) and prescribing migraine preventive medications in the ED. The study will examine the effect of these treatments, both individually and in combination, on pain severity and headache-related disability. This study is designed to examine the feasibility of comparing four interventions for ED patients presenting with migraine. Group 1: Starting topiramate; Group 2: Doing a brief behavioral intervention; Group 3: Treating with combination therapy of topiramate and behavioral intervention; and Group 4: Standard of Care.

Details

Lead sponsor	NYU Langone Health
Phase	NA
Status	WITHDRAWN
Start date	2015-12
Completion	2017-10

Conditions

• Migraine

Interventions

• Relaxation Therapy
• Topiramate
• Standard of Care
• Abortive Medication (Naproxen and Sumatriptan)

Primary outcomes

• Verbal numeric rating scale (VNRS) scores — 24 hours, 72 hours
  To examine whether there is a significant pain reduction for patients in the ED after behavioral therapy, investigators will analyze pain scores in the ED, and at 24 hours and 72 hours.
• Headache Impact Test (HIT) scores — 3 Months